HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Squamous Cell Carcinoma

Clinical trial NCT04369937 · COMPLETED

Trial details

NCT number: NCT04369937
Sponsor: Dan Zandberg
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HPV-Related Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma

Start date: 2020-07-06
Primary completion: 2025-03-12
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.